Minimally invasive surgery conferred lower survival rates than open surgery among women with cervical cancer, according to randomized phase 3 trial results presented at Society of Gynecologic Oncology 2022 Annual Meeting on Women’s Cancer.
“The minimally invasive surgical approach had worse DFS compared with the open approach, and we confirmed this after median follow up of 4.5 years for all patients who were eligible to be registered at the 4.5-year follow up. In addition to that, we noted that patients undergoing minimally invasive surgery also had significantly worse overall survival,”